Skip to content
All Podcasts – Lifestyle
Author:
Mylan Inc.
Viatris Maintains Dividend Policy for 2026 and Announces Quarterly Dividend
March 5, 2026
FDA Accepts Viatris Supplemental New Drug Application for MR-141 (Phentolamine Ophthalmic Solution 0.75%) for the Treatment of Presbyopia
March 4, 2026
←
Previous Page
1
2